title: Response.
authors.forename: Marc
authors.initials: M
authors.lastname: Brisson
authors.forename: Mélanie
authors.initials: M
authors.lastname: Drolet
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Boily
authors.forename: Talía
authors.initials: T
authors.lastname: Malagón
authors.forename: Eduardo L
authors.initials: EL
authors.lastname: Franco
authors.forename: Jean- François
authors.initials: J
authors.lastname: Laprise
authors.forename: Nicholas
authors.initials: N
authors.lastname: Van de Velde
authors.forename: Marie-Hélène
authors.initials: MH
authors.lastname: Mayrand
authors.forename: Erich V
authors.initials: EV
authors.lastname: Kliewer
authors.forename: François
authors.initials: F
authors.lastname: Coutlée
mesh_terms: D003218:Condylomata Acuminata / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D015233:Models, Statistical; D030361:Papillomavirus Infections / Q000453:epidemiology*; D053918:Papillomavirus Vaccines / Q000276:immunology*; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology*
chemical_list: D053918:Papillomavirus Vaccines